QQ客服 官方微博 反馈留言

	Cancer nanomedicine: mechanisms, obstacles and strategies
	Li Huafei[1]; Jin Hai[2]; Wan Wei[3]; Wu Cong[4]; Wei Lixin[5]
刊名	Nanomedicine (London, England)
	2018
页码	1639-1656
ISSN号	1748-6963
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2172646
专题	上海大学
作者单位	1.[1]Department of Pathology, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, 201203, PR China. 2.[2]Department of Thoracic Surgery/LaboratoryDiagnosis, First Affiliated Hospital of the Second Military Medical University,168 Changhai Road, Shanghai, 200438, PR China. 3.[3]Department of Orthopedic Oncology, Spine Tumor Center, Second Affiliated Hospital of the Second Military Medical University, 415 Fengyang Road, Shanghai, 200003, PR China. 4.[4]Department of Thoracic Surgery/LaboratoryDiagnosis, First Affiliated Hospital of the Second Military Medical University,168 Changhai Road, Shanghai, 200438, PR China. 5.[5]Tumor Immunology & Gene Therapy Center, Third Affiliated Hospital of the Second Military Medical University, 225 Changhai Road, Shanghai, 200438, PR China.
推荐引用方式 GB/T 7714	Li Huafei[1],Jin Hai[2],Wan Wei[3],et al. Cancer nanomedicine: mechanisms, obstacles and strategies[J]. Nanomedicine (London, England),2018:1639-1656.
APA	Li Huafei[1],Jin Hai[2],Wan Wei[3],Wu Cong[4],&Wei Lixin[5].(2018).Cancer nanomedicine: mechanisms, obstacles and strategies.Nanomedicine (London, England),1639-1656.
MLA	Li Huafei[1],et al."Cancer nanomedicine: mechanisms, obstacles and strategies".Nanomedicine (London, England) (2018):1639-1656.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。